Very important week for some pharameutical/biotech earnings that are reporting this week. We urge traders to be cautious and not get overly enthusiastic buying prematurely. Fine upside achieved in some minor biotechs but some have stopped out while others are lookig ready to rally off lows. Not looking for a relief to last in these sectors but rather trading them on a stock by stock basis according to chart patterns and "Anticipatory Upswing" and "Anticipatory Downswing" We still expect pullbacks and sell the report, however there also might be some gap 'n craps that bottom enough for a gap fill intraday like we got off TARO and TASR before they continued to implode.